Trial Exploring Feasibility of Densification and Optimal Sequencing of Postoperative Adjuvant Fluorouracil, Epirubicin Plus Cyclophosphamide (FEC) and Docetaxel Chemotherapy in Patients With High Risk Primary Operable Breast Cancer

NCT00256360 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
117
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Universitaire Ziekenhuizen KU Leuven

Collaborators